Stefan Peukert
Novartis (Switzerland)(CH)Novartis (China)(CN)
Publications by Year
Research Areas
Cardiac electrophysiology and arrhythmias, Ion channel regulation and function, Hedgehog Signaling Pathway Studies, Asymmetric Synthesis and Catalysis, Epigenetics and DNA Methylation
Most-Cited Works
- → Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma(2010)553 cited
- → Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist(2010)325 cited
- → Small‐Molecule Inhibitors of the Hedgehog Signaling Pathway as Cancer Therapeutics(2010)173 cited
- → Discovery of LSZ102, a Potent, Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer(2018)123 cited
- → 1-Amino-4-benzylphthalazines as Orally Bioavailable Smoothened Antagonists with Antitumor Activity(2009)106 cited
- → Molecular Basis for Kv1.5 Channel Block(2003)103 cited
- → Discovery of NVP‐LEQ506, a Second‐Generation Inhibitor of Smoothened